Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders

Journal of Nervous and Mental Disease

Volumn 197, Issue 3, 2009, Pages 172-177

  Yen, Cheng Fang ^a,b   Lee, Yu ^c   Tang, Tze Chun ^b   Yen, Ju Yu ^b,d   Ko, Chih Hung ^b   Chen, Cheng Chung ^a,b,e,f  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^e KAI SUAN PSYCHIATRIC HOSPITAL   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adherence; Adverse effects of medication; Depression; Insight

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHINESE; DEPRESSION; DYSTHYMIA; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; INTROSPECTION; LANGUAGE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICATION ADHERENCE BEHAVIOR SCALE; MENTAL DISEASE; MOOD DISORDERS INSIGHT SCALE; PATIENT COMPLIANCE; PERCEPTION; PREDICTION; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; REMISSION; SELF CONCEPT; SELF STIGMA ASSESSMENT SCALE; STIGMA; SUICIDE; SYMPTOM; TREATMENT OUTCOME; VIOLENCE; ADDICTION; ADOLESCENT; AGED; AWARENESS; COMORBIDITY; MIDDLE AGED; PATIENT ATTITUDE; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SUICIDE ATTEMPT; TAIWAN;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; AWARENESS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SELF CONCEPT; SICK ROLE; SUBSTANCE-RELATED DISORDERS; SUICIDE, ATTEMPTED; TAIWAN; YOUNG ADULT;

EID: 63149099263     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e318199fbac     Document Type: Article

References (50)

1. Aikens JE, Kroenke K, Swindle RW, Eckert GJ (2005) Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. Gen Hosp Psychiatry. 27:229-236.
2. Akincigil A, Bowblis JR, Levin C, Walkup JT, Jan S, Crystal S (2007) Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care. 45:363-369.
3. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, Gorman JM (1994) Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 51:826-836.
4. Amador XF, Friedman JH, Kasapis C, Yale SA, Flaum M, Gorrman JM (1996) Suicidal behaviour in schizophrenia and its relationship to awareness of illness. Am J Psychiatry. 153:1185-1188.
5. American Psychiatric Association (APA) (1994) Diagnostic and Statistic Manual of Mental Disorders (4th ed). Washington (DC): APA.
6. Baron RM, Kenny DA (1986) The moderator-mediator variables distinction in social psychological research: Conceptual, strategic and statistical consideration. J Pers Soc Psychol. 51:1173-1182.
7. C, Battista DR, Bruehlman R, Sereika SS, Thase ME, Dunbar-Jacob J (2005) Beliefs about antidepressant medications in primary care patients: Relationship to self-reported adherence. Med Care. 43:1203-1207.
8. Burra TA, Chen E, McIntyre RS, Grace SL, Blackmore ER, Stewart DE (2007) Predictors of self-reported antidepressant adherence. Behav Med. 32:127-134.
9. Chien CP, Cheng TA (1985) Depression in Taiwan: Epidemiological survey utilizing CES-D. Shinkeigaku Zasshi. 87:335-338.
10. Cooper-Patrick L, Powe NR, Jenckes MW, Gonzales JJ, Levine DM, Ford DE (1997) Identification of patient attitudes and preferences regarding treatment of depression. J Gen Intern Med. 12:431-438.
11. Corrigan PW, Lundin RK (2001) Don't Call Me Nuts: Coping With the Stigma of Mental Illness. Tinley Park (IL): Recovery Press.
12. JA, Rosenheck R (1998) Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 49:196-201.
13. David AS (1990) Insight and psychosis. Br J Psychiatry. 156:798-808.
14. David AS (2005) The clinical importance of insight: An overview. In XF Amador, AS David (Eds), Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders (2nd ed, pp 359-392). New York (NY): Oxford University Press.
15. Demyttenaere K (2003) Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol. 13(suppl 3):S69-S75.
16. Demyttenaere K, Enzlin P, Dewe W, Boulanger B, De Bie J, De Troyer W, Mesters P (2001) Compliance with antidepressants in a primary care setting: Beyond lack of efficacy and adverse events. J Clin Psychiatry. 62(suppl 22):30-33.
17. Donoghue J, Hylan TR (2001) Antidepressant use in clinical practice: Efficacy vs effectiveness. Br J Psychiatry Suppl. 42:S9-S17.
18. Drake RE, Gates C, Cotton PG, Whitaker A (1984) Suicide among schizophrenics. Who is at risk? J Nerv Ment Dis. 172:613-617.
19. Feinstein R, Plutchik R (1990) Violence and suicide risk assessment in the psychiatric emergency room. Compr Psychiatry. 31:337-343.
20. Harris MJ, Milich R, Corbitt EM, Hoover DW, Brady M (1992) Self-fulfilling effects of stigmatizing information on children's social interactions. J Pers Soc Psychol. 63:41-50.
21. Hasson-Ohayon I, Kravetz S, Roe D, David AS, Weiser M (2006) Insight into psychosis and quality of life. Compr Psychiatry. 47:265-269.
22. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman JM, Marek RG, Maurer TA, Meyer R, Phillips K, Ross J, Schwenk TL, Sharfstein SS, Thase ME, Wyatt RJ (1997) The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 277:333-340.
23. Ho H, Yin CC, Hwu HG, Tsuang MM (1995) Violence and suicide assessment scale: A reliability and validity study. Chin Psychiatry ROC. 9:122-128.
24. Keene MS, Eaddy MT, Mauch RP, Regan TS, Shah M, Chiao E (2005) Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs). Curr Med Res Opin. 21:1651-1658.
25. Kim CH, Jayathilake K, Meltzer HY (2003) Hopelessness, neurocognitive function and insight in schizophrenia: Relationship to suicidal behavior. Schizophr Res. 60:71-80.
26. Lin EH, Von Korff M, Ludman EJ, Rutter C, Bush TM, Simon GE, Unützer J, Walker E, Katon WJ (2003) Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry. 25:303-310.
27. Link BG (1987) Understanding labeling effects in the area of mental disorders: An assessment of the effects of expectations of rejection. Am Sociol Rev. 52:96112.
28. Link BG, Struening EL, Neese-Todd S, Asmussen S, Phelan JC (2001) Stigma as a barrier to recovery: The consequences of stigma for the self-esteem of people with mental illnesses. Psychiatr Serv. 52:1621-1626.
29. BG, Struening EL, Rahav M, Phelan JC, Nuttbrock L (1997) On stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. J Health Soc Behav. 38:177-190.
30. Markowitz FE (1998) The effects of stigma on the psychological well-being and life satisfaction of persons with mental illness. J Health Soc Behav. 39:335-347.
31. McEvoy JP (2005) The relationship between insight into psychosis and compliance with medications. In XF Amador, AS David (Eds), Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders (2nd ed, pp 311-334). New York (NY): Oxford University Press.
32. McEvoy JP, Apperson LJ, Appelbaum PS, Ortlip P, Brecosky J, Hammill K, Geller JL, Roth L (1989) Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis. 177:43-47.
33. CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K (1998) The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 55:1128-1132.
34. Radloff LS (1977) The CSE-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1:385-401.
35. Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain RL, Swindle RW (2006) Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: Analysis of administrative claims. J Manag Care Pharm. 12:43-54.
36. RC, Petersen S (1999) The relationship between insight and suicidality among patients with schizophrenia. J Nerv Ment Dis. 187:376-378. Schwartz RC, Smith SD (2004) Suicidality and psychosis: The predictive potential of symptomatology and insight into illness. J Psychiatr Res. 38:185-191.
37. Simon GE (2002) Evidence review: Efficacy and effectiveness of antidepressant treatment in primary care. Gen Hosp Psychiatry. 24:213-224.
38. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS (2001) Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 52:1615-1620.
39. Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J (2000) Multiple recurrences of major depressive disorder. Am J Psychiatry. 157:229-233.
40. Sturman ED, Sproule BA (2003) Toward the development of a mood disorders insight scale: Modification of Birchwood's Psychosis Insight Scale. J Affect Disord. 77:21-30.
41. Taylor D, Paton C, Kerwin R (2005) The South London and Maudsley NHS Trust & Oxleas NHS Trust: 2005-2006 Prescribing Guidelines. London: Taylor & Francis.
42. Wetherell JL, Unutzer J (2003) Adherence to treatment for geriatric depression and anxiety. CNS Spectrums. 8(suppl 3):48-59.
43. ER, Gronfein WP, Owens TJ (2000) Deinstitutionalization, social rejection and the self-esteem of former mental patients. J Health Soc Behav. 41:68-90.
44. Yen CF, Chen CS, Ko CH, Yeh ML, Yang SJ, Yen JY, Huang CF, Wu CC (2005a) Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: A prospective study. Psychiatry Clin Neurosci. 59:403-409.
45. Yen CF, Chen CS, Ko CH, Yen JY, Huang CF (2007) Changes in insight among patients with bipolar I disorder: A two-year prospective study. Bipolar Disord. 9:238-242.
46. Yen CF, Chen CC, Lee Y, Tang TC, Ko CH, Yen JY. Association between quality of life and self-stigma, insight and adverse effects of medication in patients with depressive disorders. Depress Anxiety. In press.
47. Yen CF, Chen CC, Lee Y, Tang TC, Ko CH, Yen JY (2005b) Insight and correlates among outpatients with depressive disorders. Compr Psychiatry. 46:384-389.
48. Yen CF, Chen CC, Lee Y, Tang TC, Yen JY, Ko CH (2005c) Self-stigma and its correlates in outpatients with depressive disorders. Psychiatr Serv. 56:599-601.
49. Yen CF, Cheng CP, Ko CH, Yen JY, Huang CF, Chen CS (2008) Suicidality and its association with insight and neurocognition in Taiwanese patients with bipolar I disorder in remission. J Nerv Ment Dis. 196:462-467.
50. Yen CF, Yeh ML, Chen CS, Chung HH (2002) Predictive value of insight for suicide, violence, hospitalization and social adjustment for outpatients with schizophrenia: A prospective study. Compr Psychiatry. 43:443-447.